Table 1 Relationship between Sialyl Lewis x expression and clinicopathological features in canine malignant mammary tumours.
Sialyl Lewis x expression | ||||
|---|---|---|---|---|
Clinical Features | Number of cases(%) | <25% | ≥25% | P value |
Histological type (n = 53) | NS(0,075) | |||
In situ carcinoma | 2 (3.8%) | 1 (50.0%) | 1 (50.0%) | |
Complex carcinoma | 13 (24.5%) | 12 (92.3%) | 1 (7.7%) | |
Tubulopapillary carcinoma | 13 (24.5%) | 7 (53.8%) | 6 (46.2%) | |
Solid carcinoma | 9 (17.0%) | 5 (55.6%) | 4 (44.4%) | |
Spindle cell carcinoma | 1 (1.9%) | 1 (100.0%) | 0 (0.0%) | |
Mucinous carcinoma | 3 (5.7%) | 1 (33.3%) | 2 (66.7%) | |
Carcinosarcoma | 10 (18.9%) | 4 (40.0%) | 6 (60.0%) | |
Carcinoma in benign tumour | 2 (3.8%) | 1 (50.0%) | 1 (50.0%) | |
Mode of Growth (n = 53) | NS(0,27) | |||
Expansive | 17 (32.1%) | 13 (76.5%) | 4 (23.5%) | |
Invasive | 28 (52.8%) | 15 (53.6%) | 13 (46.4%) | |
Vessel invasion | 8 (15.1%) | 4 (50.0%) | 4 (50.0%) | |
Lymph node metastases (n = 50)* | 0.034 | |||
No | 39 (78.0%) | 29 (74.4%) | 10 (25.6%) | |
Yes | 11 (22.0%) | 4 (36.4%) | 7 (63.6%) | |
Necrosis (n = 53) | NS(0,078) | |||
Absent | 23 (43.4%) | 17 (73.9%) | 6 (26.1%) | |
Present | 30 (56.6%) | 15 (50.0%) | 15 (50.0%) | |
Distant Metastasis (n = 33) | NS(0,24) | |||
No | 23 (69.7%) | 17 (73.9%) | 6 (26.1%) | |
Yes | 10 (30.3%) | 5 (50.0%) | 5 (50.0%) | |